RegentAtlantic Capital’s Nu Skin NUS Stock Holding History

RegentAtlantic Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-320	Closed	-$14K	–	727
2014 Q4	$14K	Buy	+320	New	+$14.1K	﹤0.01%	831

Other funds holding NUS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

RegentAtlantic Capital's NUS Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Nu Skin (NUS) in Q1 2015, closing a stake of 320 shares — an estimated $14K sold.

RegentAtlantic Capital first reported a position in NUS in Q4 2014 and held it in 1 quarter. The position peaked at $14K in Q4 2014. 203 funds tracked by Wall St. Rank hold NUS as of Q1 2015.

RegentAtlantic Capital reported no remaining Nu Skin position as of Q1 2015 after selling out during the quarter.
RegentAtlantic Capital sold 320 Nu Skin shares in Q1 2015, an estimated $14K.
RegentAtlantic Capital first reported a position in Nu Skin in Q4 2014 and held it in 1 quarter.
RegentAtlantic Capital's Nu Skin position peaked at $14K in Q4 2014.
203 funds tracked by Wall St. Rank held Nu Skin as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.